Loading…
Ras inhibition amplifies cisplatin sensitivity of human glioblastoma
Resistance to chemotherapy is a common feature of malignant gliomas. This resistance is mediated by receptor tyrosine kinase (RTK)-regulated signaling. p21-Ras protein is pivotal in the propagation of the signal originated from many RTKs. Our aim was to investigate whether inhibition of Ras pathway...
Saved in:
Published in: | Biochemical and biophysical research communications 2004-07, Vol.320 (2), p.493-500 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c383t-be51cf89bf32ac6cf031c0b9c874a069982c7d5dd4804e1db5651194f5094a173 |
---|---|
cites | cdi_FETCH-LOGICAL-c383t-be51cf89bf32ac6cf031c0b9c874a069982c7d5dd4804e1db5651194f5094a173 |
container_end_page | 500 |
container_issue | 2 |
container_start_page | 493 |
container_title | Biochemical and biophysical research communications |
container_volume | 320 |
creator | Messina, Samantha Leonetti, Carlo De Gregorio, Giorgia Affatigato, Valentina Ragona, Giuseppe Frati, Luigi Zupi, Gabriella Santoni, Angela Porcellini, Antonio |
description | Resistance to chemotherapy is a common feature of malignant gliomas. This resistance is mediated by receptor tyrosine kinase (RTK)-regulated signaling. p21-Ras protein is pivotal in the propagation of the signal originated from many RTKs. Our aim was to investigate whether inhibition of Ras pathway affects the response to cisplatin in malignant gliomas. We found an enhanced sensitivity to cisplatin of two glioblastoma cell lines expressing dominant negative Ras. Moreover, DN-Ras expressing cells, implanted in nude mice, resulted in being extremely sensitive to cisplatin. The growth of all the tumors was significantly inhibited by combining DN-Ras adenovirus infection with cisplatin treatment. The majority of glioma cells expressing DN-Ras underwent apoptosis in response to cisplatin. In vivo, DN-Ras alone did not influence the growth of tumors, suggesting that the effects of Ras-inhibition observed in vitro could not be extrapolated in vivo. The survival signal pathway transduced by Ras was essentially mediated by inhibition of caspase-9 cleavage via PI3K/Akt. |
doi_str_mv | 10.1016/j.bbrc.2004.06.003 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_66657754</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006291X04012306</els_id><sourcerecordid>66657754</sourcerecordid><originalsourceid>FETCH-LOGICAL-c383t-be51cf89bf32ac6cf031c0b9c874a069982c7d5dd4804e1db5651194f5094a173</originalsourceid><addsrcrecordid>eNqFkM1LwzAYh4Mobk7_AQ_Sk7fW922TtAEvMj9hIIiCt5Ckqcvox0zawf57Ozbwpqf38D6_5_AQcomQICC_WSVae5OkADQBngBkR2SKICBOEegxmQIAj1OBnxNyFsIKAJFycUomyFIUBeNTcv-mQuTapdOud10bqWZdu8rZEBkX1rXqXRsF24bxu3H9NuqqaDk0qo2-atfpWoW-a9Q5OalUHezF4c7Ix-PD-_w5Xrw-vczvFrHJiqyPtWVoqkLoKkuV4aaCDA1oYYqcKuBCFKnJS1aWtABqsdSMM0RBKwaCKsyzGbnee9e--x5s6GXjgrF1rVrbDUFyzlmeM_oviCLnvKDpCKZ70PguBG8rufauUX4rEeQuslzJXWS5iyyByzHyOLo62Afd2PJ3cqg6Ard7wI4xNs56GYyzrbGl89b0suzcX_4fdEqNuQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19766842</pqid></control><display><type>article</type><title>Ras inhibition amplifies cisplatin sensitivity of human glioblastoma</title><source>Elsevier</source><creator>Messina, Samantha ; Leonetti, Carlo ; De Gregorio, Giorgia ; Affatigato, Valentina ; Ragona, Giuseppe ; Frati, Luigi ; Zupi, Gabriella ; Santoni, Angela ; Porcellini, Antonio</creator><creatorcontrib>Messina, Samantha ; Leonetti, Carlo ; De Gregorio, Giorgia ; Affatigato, Valentina ; Ragona, Giuseppe ; Frati, Luigi ; Zupi, Gabriella ; Santoni, Angela ; Porcellini, Antonio</creatorcontrib><description>Resistance to chemotherapy is a common feature of malignant gliomas. This resistance is mediated by receptor tyrosine kinase (RTK)-regulated signaling. p21-Ras protein is pivotal in the propagation of the signal originated from many RTKs. Our aim was to investigate whether inhibition of Ras pathway affects the response to cisplatin in malignant gliomas. We found an enhanced sensitivity to cisplatin of two glioblastoma cell lines expressing dominant negative Ras. Moreover, DN-Ras expressing cells, implanted in nude mice, resulted in being extremely sensitive to cisplatin. The growth of all the tumors was significantly inhibited by combining DN-Ras adenovirus infection with cisplatin treatment. The majority of glioma cells expressing DN-Ras underwent apoptosis in response to cisplatin. In vivo, DN-Ras alone did not influence the growth of tumors, suggesting that the effects of Ras-inhibition observed in vitro could not be extrapolated in vivo. The survival signal pathway transduced by Ras was essentially mediated by inhibition of caspase-9 cleavage via PI3K/Akt.</description><identifier>ISSN: 0006-291X</identifier><identifier>EISSN: 1090-2104</identifier><identifier>DOI: 10.1016/j.bbrc.2004.06.003</identifier><identifier>PMID: 15219856</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adenoviridae - genetics ; Adenovirus ; Animals ; Antineoplastic Agents - pharmacology ; Apoptosis ; Brain Neoplasms - pathology ; Cell Line, Tumor ; Chemotherapy ; Cisplatin - pharmacology ; Drug resistance ; Enzyme Activation ; Gene therapy ; Glioblastoma ; Glioblastoma - pathology ; Humans ; Male ; Mice ; Mice, Nude ; Neoplasm Transplantation ; Phosphatidylinositol 3-Kinases - metabolism ; Protein-Serine-Threonine Kinases - metabolism ; Proto-Oncogene Proteins - metabolism ; Proto-Oncogene Proteins c-akt ; Ras ; ras Proteins - antagonists & inhibitors ; ras Proteins - genetics ; Signal transduction</subject><ispartof>Biochemical and biophysical research communications, 2004-07, Vol.320 (2), p.493-500</ispartof><rights>2004 Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c383t-be51cf89bf32ac6cf031c0b9c874a069982c7d5dd4804e1db5651194f5094a173</citedby><cites>FETCH-LOGICAL-c383t-be51cf89bf32ac6cf031c0b9c874a069982c7d5dd4804e1db5651194f5094a173</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15219856$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Messina, Samantha</creatorcontrib><creatorcontrib>Leonetti, Carlo</creatorcontrib><creatorcontrib>De Gregorio, Giorgia</creatorcontrib><creatorcontrib>Affatigato, Valentina</creatorcontrib><creatorcontrib>Ragona, Giuseppe</creatorcontrib><creatorcontrib>Frati, Luigi</creatorcontrib><creatorcontrib>Zupi, Gabriella</creatorcontrib><creatorcontrib>Santoni, Angela</creatorcontrib><creatorcontrib>Porcellini, Antonio</creatorcontrib><title>Ras inhibition amplifies cisplatin sensitivity of human glioblastoma</title><title>Biochemical and biophysical research communications</title><addtitle>Biochem Biophys Res Commun</addtitle><description>Resistance to chemotherapy is a common feature of malignant gliomas. This resistance is mediated by receptor tyrosine kinase (RTK)-regulated signaling. p21-Ras protein is pivotal in the propagation of the signal originated from many RTKs. Our aim was to investigate whether inhibition of Ras pathway affects the response to cisplatin in malignant gliomas. We found an enhanced sensitivity to cisplatin of two glioblastoma cell lines expressing dominant negative Ras. Moreover, DN-Ras expressing cells, implanted in nude mice, resulted in being extremely sensitive to cisplatin. The growth of all the tumors was significantly inhibited by combining DN-Ras adenovirus infection with cisplatin treatment. The majority of glioma cells expressing DN-Ras underwent apoptosis in response to cisplatin. In vivo, DN-Ras alone did not influence the growth of tumors, suggesting that the effects of Ras-inhibition observed in vitro could not be extrapolated in vivo. The survival signal pathway transduced by Ras was essentially mediated by inhibition of caspase-9 cleavage via PI3K/Akt.</description><subject>Adenoviridae - genetics</subject><subject>Adenovirus</subject><subject>Animals</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Apoptosis</subject><subject>Brain Neoplasms - pathology</subject><subject>Cell Line, Tumor</subject><subject>Chemotherapy</subject><subject>Cisplatin - pharmacology</subject><subject>Drug resistance</subject><subject>Enzyme Activation</subject><subject>Gene therapy</subject><subject>Glioblastoma</subject><subject>Glioblastoma - pathology</subject><subject>Humans</subject><subject>Male</subject><subject>Mice</subject><subject>Mice, Nude</subject><subject>Neoplasm Transplantation</subject><subject>Phosphatidylinositol 3-Kinases - metabolism</subject><subject>Protein-Serine-Threonine Kinases - metabolism</subject><subject>Proto-Oncogene Proteins - metabolism</subject><subject>Proto-Oncogene Proteins c-akt</subject><subject>Ras</subject><subject>ras Proteins - antagonists & inhibitors</subject><subject>ras Proteins - genetics</subject><subject>Signal transduction</subject><issn>0006-291X</issn><issn>1090-2104</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><recordid>eNqFkM1LwzAYh4Mobk7_AQ_Sk7fW922TtAEvMj9hIIiCt5Ckqcvox0zawf57Ozbwpqf38D6_5_AQcomQICC_WSVae5OkADQBngBkR2SKICBOEegxmQIAj1OBnxNyFsIKAJFycUomyFIUBeNTcv-mQuTapdOud10bqWZdu8rZEBkX1rXqXRsF24bxu3H9NuqqaDk0qo2-atfpWoW-a9Q5OalUHezF4c7Ix-PD-_w5Xrw-vczvFrHJiqyPtWVoqkLoKkuV4aaCDA1oYYqcKuBCFKnJS1aWtABqsdSMM0RBKwaCKsyzGbnee9e--x5s6GXjgrF1rVrbDUFyzlmeM_oviCLnvKDpCKZ70PguBG8rufauUX4rEeQuslzJXWS5iyyByzHyOLo62Afd2PJ3cqg6Ard7wI4xNs56GYyzrbGl89b0suzcX_4fdEqNuQ</recordid><startdate>20040723</startdate><enddate>20040723</enddate><creator>Messina, Samantha</creator><creator>Leonetti, Carlo</creator><creator>De Gregorio, Giorgia</creator><creator>Affatigato, Valentina</creator><creator>Ragona, Giuseppe</creator><creator>Frati, Luigi</creator><creator>Zupi, Gabriella</creator><creator>Santoni, Angela</creator><creator>Porcellini, Antonio</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U9</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>20040723</creationdate><title>Ras inhibition amplifies cisplatin sensitivity of human glioblastoma</title><author>Messina, Samantha ; Leonetti, Carlo ; De Gregorio, Giorgia ; Affatigato, Valentina ; Ragona, Giuseppe ; Frati, Luigi ; Zupi, Gabriella ; Santoni, Angela ; Porcellini, Antonio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c383t-be51cf89bf32ac6cf031c0b9c874a069982c7d5dd4804e1db5651194f5094a173</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adenoviridae - genetics</topic><topic>Adenovirus</topic><topic>Animals</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Apoptosis</topic><topic>Brain Neoplasms - pathology</topic><topic>Cell Line, Tumor</topic><topic>Chemotherapy</topic><topic>Cisplatin - pharmacology</topic><topic>Drug resistance</topic><topic>Enzyme Activation</topic><topic>Gene therapy</topic><topic>Glioblastoma</topic><topic>Glioblastoma - pathology</topic><topic>Humans</topic><topic>Male</topic><topic>Mice</topic><topic>Mice, Nude</topic><topic>Neoplasm Transplantation</topic><topic>Phosphatidylinositol 3-Kinases - metabolism</topic><topic>Protein-Serine-Threonine Kinases - metabolism</topic><topic>Proto-Oncogene Proteins - metabolism</topic><topic>Proto-Oncogene Proteins c-akt</topic><topic>Ras</topic><topic>ras Proteins - antagonists & inhibitors</topic><topic>ras Proteins - genetics</topic><topic>Signal transduction</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Messina, Samantha</creatorcontrib><creatorcontrib>Leonetti, Carlo</creatorcontrib><creatorcontrib>De Gregorio, Giorgia</creatorcontrib><creatorcontrib>Affatigato, Valentina</creatorcontrib><creatorcontrib>Ragona, Giuseppe</creatorcontrib><creatorcontrib>Frati, Luigi</creatorcontrib><creatorcontrib>Zupi, Gabriella</creatorcontrib><creatorcontrib>Santoni, Angela</creatorcontrib><creatorcontrib>Porcellini, Antonio</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Biochemical and biophysical research communications</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Messina, Samantha</au><au>Leonetti, Carlo</au><au>De Gregorio, Giorgia</au><au>Affatigato, Valentina</au><au>Ragona, Giuseppe</au><au>Frati, Luigi</au><au>Zupi, Gabriella</au><au>Santoni, Angela</au><au>Porcellini, Antonio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ras inhibition amplifies cisplatin sensitivity of human glioblastoma</atitle><jtitle>Biochemical and biophysical research communications</jtitle><addtitle>Biochem Biophys Res Commun</addtitle><date>2004-07-23</date><risdate>2004</risdate><volume>320</volume><issue>2</issue><spage>493</spage><epage>500</epage><pages>493-500</pages><issn>0006-291X</issn><eissn>1090-2104</eissn><abstract>Resistance to chemotherapy is a common feature of malignant gliomas. This resistance is mediated by receptor tyrosine kinase (RTK)-regulated signaling. p21-Ras protein is pivotal in the propagation of the signal originated from many RTKs. Our aim was to investigate whether inhibition of Ras pathway affects the response to cisplatin in malignant gliomas. We found an enhanced sensitivity to cisplatin of two glioblastoma cell lines expressing dominant negative Ras. Moreover, DN-Ras expressing cells, implanted in nude mice, resulted in being extremely sensitive to cisplatin. The growth of all the tumors was significantly inhibited by combining DN-Ras adenovirus infection with cisplatin treatment. The majority of glioma cells expressing DN-Ras underwent apoptosis in response to cisplatin. In vivo, DN-Ras alone did not influence the growth of tumors, suggesting that the effects of Ras-inhibition observed in vitro could not be extrapolated in vivo. The survival signal pathway transduced by Ras was essentially mediated by inhibition of caspase-9 cleavage via PI3K/Akt.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>15219856</pmid><doi>10.1016/j.bbrc.2004.06.003</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0006-291X |
ispartof | Biochemical and biophysical research communications, 2004-07, Vol.320 (2), p.493-500 |
issn | 0006-291X 1090-2104 |
language | eng |
recordid | cdi_proquest_miscellaneous_66657754 |
source | Elsevier |
subjects | Adenoviridae - genetics Adenovirus Animals Antineoplastic Agents - pharmacology Apoptosis Brain Neoplasms - pathology Cell Line, Tumor Chemotherapy Cisplatin - pharmacology Drug resistance Enzyme Activation Gene therapy Glioblastoma Glioblastoma - pathology Humans Male Mice Mice, Nude Neoplasm Transplantation Phosphatidylinositol 3-Kinases - metabolism Protein-Serine-Threonine Kinases - metabolism Proto-Oncogene Proteins - metabolism Proto-Oncogene Proteins c-akt Ras ras Proteins - antagonists & inhibitors ras Proteins - genetics Signal transduction |
title | Ras inhibition amplifies cisplatin sensitivity of human glioblastoma |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T22%3A51%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ras%20inhibition%20amplifies%20cisplatin%20sensitivity%20of%20human%20glioblastoma&rft.jtitle=Biochemical%20and%20biophysical%20research%20communications&rft.au=Messina,%20Samantha&rft.date=2004-07-23&rft.volume=320&rft.issue=2&rft.spage=493&rft.epage=500&rft.pages=493-500&rft.issn=0006-291X&rft.eissn=1090-2104&rft_id=info:doi/10.1016/j.bbrc.2004.06.003&rft_dat=%3Cproquest_cross%3E66657754%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c383t-be51cf89bf32ac6cf031c0b9c874a069982c7d5dd4804e1db5651194f5094a173%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=19766842&rft_id=info:pmid/15219856&rfr_iscdi=true |